ADC Therapeutics SA (ADCT)
USD 1.91
(-10.33%)
USD 1.91
(-10.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -118.68 Million | -136.79 Million | -233.37 Million | -168.72 Million | -121.58 Million | -121.36 Million |
| Net Income | -240.05 Million | -155.8 Million | -230.02 Million | -246.29 Million | -116.48 Million | -123.09 Million |
| Depreciation & Amortization | 3.26 Million | 2.32 Million | 2.63 Million | 2.18 Million | 1.64 Million | 740 Thousand |
| Deferred income taxes | 37.1 Million | -708 Thousand | -21.47 Million | 327 Thousand | 1.2 Million | 935 Thousand |
| Stock-based compensation | 13.49 Million | 49.32 Million | 60.48 Million | 37.58 Million | 1.11 Million | 469 Thousand |
| Change in working capital | 44.27 Million | -33.01 Million | -20.28 Million | 12.36 Million | -7.88 Million | 481 Thousand |
| Other non-cash items | 23.23 Million | 1.07 Million | -24.7 Million | 25.09 Million | -1.18 Million | -891 Thousand |
| Investing Cash Flow | -3.21 Million | -2.5 Million | -6.67 Million | -2.82 Million | -2.24 Million | -2.5 Million |
| Investments in PPE | -3.21 Million | -2.29 Million | -6.37 Million | -2.8 Million | -2.14 Million | -2.47 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -210 Thousand | -297 Thousand | -19 Thousand | -100 Thousand | -36 Thousand |
| Financing Cash Flow | 73.87 Million | -593 Thousand | 267.39 Million | 494.96 Million | 100.51 Million | -24 Thousand |
| Debt repayment | - | -1.01 Million | -977 Thousand | -1.14 Million | -1 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -221 Thousand | - | - | -141 Thousand | -24 Thousand |
| Common Stock Issuance | 773 Thousand | 6.13 Million | 778 Thousand | 433.15 Million | 41 Thousand | - |
| Other Financing Activities | 73.1 Million | -5.49 Million | 267.59 Million | 62.95 Million | 101.61 Million | -24 Thousand |
| Accounts receivables | 47.78 Million | -42.75 Million | -30.21 Million | - | 192 Thousand | 895 Thousand |
| Accounts payables | 3.17 Million | 310 Thousand | 6.79 Million | 1.92 Million | -3.42 Million | -858 Thousand |
| Inventory | -5.71 Million | -8.96 Million | -3.02 Million | - | -2.31 Million | 1.58 Million |
| Other working capital | -979 Thousand | 18.39 Million | 6.16 Million | 10.44 Million | -2.34 Million | -1.14 Million |
| Cash at beginning of period | 326.44 Million | 466.54 Million | 439.19 Million | 115.55 Million | 138.8 Million | 262.75 Million |
| Cash at end of period | 278.59 Million | 326.44 Million | 466.54 Million | 439.19 Million | 115.55 Million | 138.8 Million |
| Capital Expenditure | -3.21 Million | -2.29 Million | -6.37 Million | -2.8 Million | -2.14 Million | -2.47 Million |
| Effect of forex changes on cash | 184 Thousand | -208 Thousand | 6000.00 | 235 Thousand | 61 Thousand | -53 Thousand |
| Net cash flow / Change in cash | -47.84 Million | -140.1 Million | 27.34 Million | 323.64 Million | -23.25 Million | -123.94 Million |
| Free Cash Flow | -121.9 Million | -139.09 Million | -239.75 Million | -171.53 Million | -123.72 Million | -123.83 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -36.54 Million | -46.6 Million | -85.7 Million | -240.05 Million | -47.8 Million | -47.11 Million |
| Depreciation & Amortization | 838 Thousand | 843 Thousand | 1.01 Million | 3.26 Million | 793 Thousand | 769 Thousand |
| Deferred income taxes | - | - | 45.74 Million | 37.1 Million | -578 Thousand | -7.21 Million |
| Stock-based compensation | 1.98 Million | 158 Thousand | 1.55 Million | 13.49 Million | 2.5 Million | 1.36 Million |
| Change in working capital | -4.57 Million | -9.92 Million | 10.18 Million | 44.27 Million | 224 Thousand | 251 Thousand |
| Other non-cash items | 14.31 Million | 13.09 Million | -5.86 Million | 23.23 Million | 10.84 Million | 15.37 Million |
| Investing Cash Flow | -20.79 Thousand | -531 Thousand | -527 Thousand | -3.21 Million | -661 Thousand | -1.01 Million |
| Investments in PPE | -20.79 Thousand | -531 Thousand | -327 Thousand | -3.21 Million | -661 Thousand | -1.21 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -200 Thousand | - | 2006.54 | 200 Thousand |
| Financing Cash Flow | 97.07 Million | 356 Thousand | 1.63 Million | 73.87 Million | -2.3 Million | 74.73 Million |
| Debt repayment | - | - | -866 Thousand | - | -409 Thousand | -261 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 97.07 Million | 356 Thousand | 782.96 Thousand | 773 Thousand | - | - |
| Other Financing Activities | 98.69 Million | 356 Thousand | 856.03 Thousand | 73.1 Million | -1.89 Million | 75 Million |
| Accounts receivables | 281.05 Thousand | 1.99 Million | -3.99 Million | 47.78 Million | 2.69 Million | 188 Thousand |
| Accounts payables | -4.73 Million | -1.24 Million | 6.57 Million | 3.17 Million | -836 Thousand | 1.1 Million |
| Inventory | 518.81 Thousand | -568 Thousand | -332 Thousand | -5.71 Million | -3.3 Million | -1.9 Million |
| Other working capital | -640.87 Thousand | -10.1 Million | 7.94 Million | -979 Thousand | 1.66 Million | 866 Thousand |
| Cash at beginning of period | 234.28 Million | 278.59 Million | 310.4 Million | 326.44 Million | 347.51 Million | 310.54 Million |
| Cash at end of period | 300.11 Million | 234.28 Million | 278.59 Million | 278.59 Million | 310.4 Million | 347.51 Million |
| Capital Expenditure | -20.79 Thousand | -531 Thousand | -327 Thousand | -3.21 Million | -661 Thousand | -1.21 Million |
| Effect of forex changes on cash | 12 Thousand | -43 Thousand | 152 Thousand | 184 Thousand | -118 Thousand | 61 Thousand |
| Net cash flow / Change in cash | 65.83 Million | -44.31 Million | -31.8 Million | -47.84 Million | -37.1 Million | 36.96 Million |
| Free Cash Flow | -31.6 Million | -44.62 Million | -33.4 Million | -121.9 Million | -34.67 Million | -38.03 Million |
ACF
PTCIL
GUJALKALI
TITANSEC
PGXFF
600628